A Randomized Double-blind Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)
Latest Information Update: 03 Feb 2025
At a glance
- Drugs Estetrol (Primary) ; Progesterone
- Indications Hot flashes; Vasomotor symptoms
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms E4Comfort Study I
- Sponsors Estetra SPRL
Most Recent Events
- 15 Oct 2024 Status changed from active, no longer recruiting to completed.
- 12 May 2024 This trial has been completed in Hungary, according to European Clinical Trials Database record.
- 25 Apr 2024 This trial has been completed in Poland (Global end date: 8 Feb 2024).